South & Central America Medical Injection Molding Market Overview, Growth, Trends, Analysis, Research Report (2024-2031)

The South & Central America Medical Injection Molding Market size is expected to reach US$ 578.2 Million by 2031 from US$ 474.1 Million in 2024. The market is estimated to record a CAGR of 2.9% from 2024 to 2031.

Executive Summary and South & Central America Medical Injection Molding Market Analysis:

The medical injection moulding market in South & Central America is segmented into Brazil, Argentina, and the remainder of South & Central America. It currently is a developing market with a higher growth potential driven by the rising prevalence of chronic illness and the combined demand for affordable, yet high-quality medical devices. Manufacturers are now adopting injection moulding technology at increasing rates due to its ability to deliver precise, reliable, and cost-effective components used in a wide range of medical applications. The sheer growth in the population of older adults is also boosting demand for sophisticated healthcare delivery systems such as disposable and minimally invasive medical devices. The region is also experiencing a gradual shift towards advanced treatment practices that are focused on patient comfort and reduced recovery times that have the potential to assist the production of medical consumables such as syringes, catheters, and diagnostic components. Brazil is helping to fuel growth as one of the region's largest health care markets with healthcare expansion and domestic medical manufacturing capacity investment leading the charge.

South & Central America Medical Injection Molding Market: Strategic Insights

South & Central America Medical Injection Molding Market Segmentation Analysis:

• By Material, the South & Central America Medical Injection Molding Market is segmented into Polyvinyl Chloride (PVC), Poly(methyl methacrylate) (PMMA), Polyether Ether Ketone (PEEK), Metals, and Others. Others held the largest share of the market in 2024.
• By Type, the South & Central America Medical Injection Molding Market is segmented into Plastic Injection Molding, Overmolding, Liquid Silicone Molding, and Others. Plastic Injection Molding held the largest share of the market in 2024.
• By End User, the South & Central America Medical Injection Molding Market is segmented into Medical Devices Companies, Pharmaceutical Drug Packaging Companies, Surgical Instruments Companies, and Others. Medical Devices Companies held the largest share of the market in 2024.
• By Product Type, the South & Central America Medical Injection Molding Market is segmented into Medical Equipment Components, Consumables, Patient Aids, Orthopedic Instruments, Dental Products, and Others. Medical Equipment Components held the largest share of the market in 2024.
• By System, the South & Central America Medical Injection Molding Market is segmented into Hot Runner and Cold Runner. Hot Runner held the largest share of the market in 2024.

South & Central America Medical Injection Molding Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Medical Injection Molding Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

South & Central America Medical Injection Molding Market Outlook

Advancements such as all-electric injection moulding and micro-moulding have made a big difference in the production of medical devices, thereby fueling the overall medical injection moulding market progress. All-electric machines are especially valuable for their energy efficiency and precise control, which are essential when manufacturing high-quality medical components. These machines can operate compatibly in cleanroom environments, ensuring contamination-free output that meets strict hygiene standards. Micro-moulding, on the other hand, allows for the creation of incredibly small and precise parts, which is crucial for producing miniature medical devices such as implants and diagnostic tools. Together, these innovations are improving manufacturing processes, reducing waste, and making it easier to maintain the high standards required for medical devices.

Several companies, including MTD Micro Moulding, Makuta Technics Inc., Accumold, Sungplastic, and WestFall Technik, have made significant advancements in injection moulding technologies, particularly in all-electric machines and micro-moulding, to enhance the precision, efficiency, and cleanliness of medical device manufacturing process. In 2021, MTD Micro Moulding celebrated the grand opening of its expanded medical micro injection moulding facility. This expansion was designed to accommodate the burgeoning demand for ultra-precision molded components in the medical device industry. In April 2021, Tederic Machinery Co. launched the NEO series of electric, hybrid injection moulding machines. These machines feature a new generation of servo pumps, enabling energy savings of up to 80% compared to traditional hydraulic machines. Additionally, in September 2020, ENGEL introduced e-speed injection moulding machines, hybrid machines (2,800 kN) used in the production of thin-walled containers, buckets, lids, etc.

Various governments provide subsidies for healthcare equipment and funding for research into medical devices as part of efforts to support healthcare expansion.
The adoption of micro-moulding technologies has enabled the creation of highly precise and miniature parts, which are vital for the development of modern medical devices. At the same time, there is a growing trend toward using bio-based materials to meet the increasing demand for environmentally sustainable and safe medical products. Companies such as Accumold, MTD Micro Moulding, and Makuta Technics highly focus on bolstering their micro-moulding capabilities, enhancing their production processes to cater to the need for small, complex medical components. These companies continue to innovate and optimize their manufacturing methods to deliver parts with exceptional precision. Similarly, firms such as DuPont and Cavestro are at the forefront of advancements in bio-based materials, which is evident through the launch of bio-based Tyvek and bio-based polycarbonate, respectively. Both companies are committed to offering more sustainable solutions, ensuring that the materials used in medical devices are both high-performing and environmentally friendly.

South & Central America Medical Injection Molding Market Country Insights

By country, the South & Central America Medical Injection Molding Market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil held the largest share in 2024.

Brazil faces a high burden of chronic diseases. Diabetes is one of the most prominent chronic diseases, and the number of people with diabetes has more than doubled over the past three decades. The International Diabetes Federation (IDF) Diabetes Atlas 2021 estimated that 15.7 million people aged 20-79 had diabetes in Brazil. The number is expected to reach 23.2 million by 2045. These alarming statistics highlight the need for advanced medical devices to manage and treat these conditions effectively. Additionally, with the aging population, the country generates a significant demand for orthopedic devices and other medical technologies. According to the Pan American Health Organization, Brazil's population aged 60 years and above reached ~30 million in 2022, representing 13% of its overall population. By 2030, this age group is expected to reach nearly 50 million, which will be 24% of the total Brazilian population. Elderly people are at a high risk of developing chronic diseases. Medical injection moulding has been instrumental in producing devices for chronic disease management. For instance, injection molded components account for the precision and reliability of insulin pens and glucose monitoring systems, which are essential for diabetes care.

South & Central America Medical Injection Molding Market Company Profiles

Some of the key players operating in the market include Biomerics LLC, Ensinger, Aberdeen Technologies, Inc., Husky Technologies, The Rodon Group, Kaysun Corporation, UPG International, C&J Industries, Sanner GmbH, Feronyl, HTI Plastics, Tessy Plastics, and Proto Labs.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South & Central America Medical Injection Molding Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise